GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Aug 4, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on August 4, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not indicate any new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Merrill Lynch International (company) — Corporate stockbroker
- August 2025 (date) — Reporting period
- 31¼ pence (dollar_amount) — Nominal value of ordinary shares
FAQ
What was the total number of GSK ordinary shares purchased?
The filing states that a 'number' of ordinary shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
On what date did the share purchase transaction occur?
The filing indicates the report is for the month of August 2025 and mentions 'Date of purcha' but does not provide a specific date for the transaction within the provided text.
Who acted as GSK's corporate stockbroker for this transaction?
Merrill Lynch International acted as GSK's corporate stockbroker for the purchase of its own shares.
What is the nominal value of GSK's ordinary shares?
The nominal value of GSK's ordinary shares is 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 4, 2025 regarding GSK plc (GLAXF).